Vilas Fund LP Purchases 38,000 Shares of CVS Health Corp (NYSE:CVS)

Vilas Fund LP lifted its position in CVS Health Corp (NYSE:CVS) by 14.6% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 298,000 shares of the pharmacy operator’s stock after acquiring an additional 38,000 shares during the period. CVS Health accounts for 19.9% of Vilas Fund LP’s holdings, making the stock its largest position. Vilas Fund LP’s holdings in CVS Health were worth $16,238,000 at the end of the most recent quarter.

Other large investors have also recently modified their holdings of the company. FMR LLC lifted its position in CVS Health by 30.6% during the fourth quarter. FMR LLC now owns 39,263,265 shares of the pharmacy operator’s stock worth $2,572,528,000 after buying an additional 9,194,005 shares in the last quarter. Geode Capital Management LLC lifted its position in CVS Health by 36.2% during the fourth quarter. Geode Capital Management LLC now owns 16,462,292 shares of the pharmacy operator’s stock worth $1,076,697,000 after buying an additional 4,376,604 shares in the last quarter. Dimensional Fund Advisors LP raised its position in CVS Health by 28.3% in the fourth quarter. Dimensional Fund Advisors LP now owns 13,790,753 shares of the pharmacy operator’s stock valued at $903,574,000 after purchasing an additional 3,041,266 shares during the period. Norges Bank purchased a new stake in CVS Health in the fourth quarter valued at $840,254,000. Finally, Nordea Investment Management AB raised its position in CVS Health by 2.8% in the first quarter. Nordea Investment Management AB now owns 12,426,745 shares of the pharmacy operator’s stock valued at $670,172,000 after purchasing an additional 340,315 shares during the period. 75.20% of the stock is currently owned by hedge funds and other institutional investors.

A number of research firms have commented on CVS. UBS Group reduced their target price on CVS Health from $74.00 to $67.00 and set a “sell” rating on the stock in a research report on Thursday, May 2nd. Standpoint Research upgraded CVS Health from a “hold” rating to a “buy” rating in a research report on Wednesday, June 5th. Citigroup lifted their target price on CVS Health from $68.00 to $72.00 and gave the company a “buy” rating in a research report on Thursday, August 8th. Morgan Stanley restated a “buy” rating and issued a $74.00 target price on shares of CVS Health in a research report on Sunday, August 11th. Finally, Mizuho set a $71.00 target price on CVS Health and gave the company a “buy” rating in a research report on Wednesday, June 5th. Two investment analysts have rated the stock with a sell rating, seven have given a hold rating, sixteen have assigned a buy rating and one has given a strong buy rating to the company’s stock. CVS Health presently has an average rating of “Buy” and an average price target of $75.14.

Shares of CVS stock traded up $1.00 on Monday, hitting $61.29. The stock had a trading volume of 4,181,214 shares, compared to its average volume of 8,699,430. CVS Health Corp has a 1 year low of $51.72 and a 1 year high of $82.15. The firm has a market capitalization of $76.52 billion, a P/E ratio of 8.66, a P/E/G ratio of 1.29 and a beta of 0.90. The company has a debt-to-equity ratio of 1.39, a current ratio of 0.95 and a quick ratio of 0.64. The company’s 50 day moving average price is $56.43 and its 200-day moving average price is $56.34.

CVS Health (NYSE:CVS) last released its quarterly earnings data on Wednesday, August 7th. The pharmacy operator reported $1.89 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.70 by $0.19. The business had revenue of $63.43 billion during the quarter, compared to analysts’ expectations of $62.66 billion. CVS Health had a return on equity of 16.15% and a net margin of 1.91%. The business’s quarterly revenue was up 35.2% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.69 EPS. On average, equities analysts forecast that CVS Health Corp will post 6.96 EPS for the current year.

The firm also recently disclosed a quarterly dividend, which was paid on Friday, August 2nd. Stockholders of record on Thursday, July 25th were given a dividend of $0.50 per share. The ex-dividend date of this dividend was Wednesday, July 24th. This represents a $2.00 annualized dividend and a dividend yield of 3.26%. CVS Health’s dividend payout ratio is currently 28.25%.

About CVS Health

CVS Health Corporation provides health services and plans in the United States. Its Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, Medicare Part D, clinical, disease management, and medical spend management services.

Further Reading: Street Name

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corp (NYSE:CVS).

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.